Retinoic acid receptor-related orphan receptors gamma inverse agonists (Allergan)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRetinoic acid receptor-related orphan receptors gamma inverse agonists (Allergan)
Drug Alias NameRetinoic acid receptor-related orphan receptors gamma inverse agonists (Vitae Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor gamma inverse agonists
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVitae Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan PlcVitae Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A